Feature

White House pushes transparency in drug price plan


 


“It’s time to end the global freeloading once and for all,” President Trump said. “I have directed U.S. Trade Representative Bob Lighthizer to make fixing this injustice a top priority with every trading partner.”

One proposal President Trump campaigned on – giving the federal government the power to directly negotiate for drug prices – was not included in the plan.

“I am very disappointed that he has apparently dropped his support for allowing Medicare to negotiate the price of prescription drugs,” Sen. Maggie Hassan (D-N.H.) said in a statement.

Also absent from the plan: a direct negotiation tactic for Part B drugs supported by Mr. Azar during his confirmation hearings.

Pages

Recommended Reading

Psychiatrists urged to take lead in recognizing physician burnout
MDedge Psychiatry
MDedge Daily News: Where the latest HCV drug combos fit in
MDedge Psychiatry
HHS says no to lifetime limits on Medicaid
MDedge Psychiatry
Uninsured rate on the rise
MDedge Psychiatry
MDedge Daily News: Research reveals surprises in mental health and gun violence
MDedge Psychiatry
The Goldwater Rule and the public good
MDedge Psychiatry
MDedge Daily News: Deep concern surrounding Title X changes
MDedge Psychiatry
MDedge Daily News: Do HPV vaccines really cut cancer risk?
MDedge Psychiatry
White House targets CHIP, CMMI for budget cuts
MDedge Psychiatry
New Medicare cards
MDedge Psychiatry